When treating pulmonary diseases such as asthma, COPD and CF, inhalation may be the best route of administration due to the rapid clinical response and the high doses of drug that can be administered to the disease site with limited off-target effects. However, a number of considerations need to be taken into account when designing new inhaled therapies. Direct drug delivery into the lung has proven to be advantageous for the treatment of chronic lung diseases due to the lower risk of side effects. However, such drugs must be poorly absorbed across the epithelia. More recently, groups are taking advantage of rapid pulmonary drug absorption and are investigating how to treat systemic diseases through pulmonary drug delivery since this allows for drug delivery that bypasses the stomach. (Jean Tyrrell and Robert Tarran, Gaining the Upper Hand on Pulmonary Drug Delivery)
Free Medical Journals from OMICS Group International has started to disseminate the peer-reviewed scholarly and academic content to scientific community with free access and to provide the unrestricted distribution of the scholarly knowledge under creative commons attribution license for the benefit of humankind. Our free medical journals are completely open access journals and publish high quality articles from the corners of the globe to update the recent developments in the fields of medical sciences.Medical Journals provide a platform for outstanding research around the globe in the field of medicine. These scholarly journals aim to contribute to the progress and application of scientific discoveries, by providing free access to the research information.
Last date updated on April, 2024
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi